Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
20.08.25
/
50%
€57.65
Target price
20.08.26
€105.76
Performance (%)
-49.84%
Price
20.03.26
€28.56
Summary
This prediction is currently active. Massive losses of -49.84% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -9.792% | -9.792% |
| iShares Core DAX® | -4,93 % | -11,98 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % |
| iShares S&P 500 | -2,54 % | -3,54 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
27.02.26
27.02.26
€93.24
27.02.27
27.02.27
-11.83%
20.03.26
20.03.26
